These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21045204)

  • 41. MicroRNAs in vascular disease.
    Qin S; Zhang C
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):8-12. PubMed ID: 21052012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
    Kaucsár T; Rácz Z; Hamar P
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inter- and intra-combinatorial regulation by transcription factors and microRNAs.
    Zhou Y; Ferguson J; Chang JT; Kluger Y
    BMC Genomics; 2007 Oct; 8():396. PubMed ID: 17971223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. microRNA therapeutics in cardiovascular disease models.
    Dangwal S; Thum T
    Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
    Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
    Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNAs as novel players in skin development, homeostasis and disease.
    Schneider MR
    Br J Dermatol; 2012 Jan; 166(1):22-8. PubMed ID: 21824129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The therapeutic potential of microRNAs in nervous system damage, degeneration, and repair.
    Hutchison ER; Okun E; Mattson MP
    Neuromolecular Med; 2009; 11(3):153-61. PubMed ID: 19763905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.
    Ibrahim AF; Weirauch U; Thomas M; Grünweller A; Hartmann RK; Aigner A
    Cancer Res; 2011 Aug; 71(15):5214-24. PubMed ID: 21690566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small Molecules with Big Impacts on Cardiovascular Diseases.
    Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
    Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymer-based delivery of RNA-based therapeutics in ovarian cancer.
    Weirauch U; Gutsch D; Höbel S; Aigner A
    Methods Mol Biol; 2013; 1049():443-65. PubMed ID: 23913237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
    Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
    Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses.
    Pérez-Sánchez L; Patiño-Trives AM; Aguirre-Zamorano MÁ; Luque-Tévar M; Ábalos-Aguilera MC; Arias-de la Rosa I; Seguí P; Velasco-Gimena F; Barbarroja N; Escudero-Contreras A; Collantes-Estévez E; Pérez-Sánchez C; López-Pedrera C
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):865-877. PubMed ID: 33356391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory microRNA networks: complex patterns of target pathways for disease-related and housekeeping microRNAs.
    Zafari S; Backes C; Leidinger P; Meese E; Keller A
    Genomics Proteomics Bioinformatics; 2015 Jun; 13(3):159-68. PubMed ID: 26169798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNAs and vascular (dys)function.
    Hartmann D; Thum T
    Vascul Pharmacol; 2011 Oct; 55(4):92-105. PubMed ID: 21802526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of cardiac microRNAs induced by aerobic exercise training during heart failure.
    Souza RW; Fernandez GJ; Cunha JP; Piedade WP; Soares LC; Souza PA; de Campos DH; Okoshi K; Cicogna AC; Dal-Pai-Silva M; Carvalho RF
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1629-41. PubMed ID: 26408546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miRNA Targeting Drugs: The Next Blockbusters?
    Schmidt MF
    Methods Mol Biol; 2017; 1517():3-22. PubMed ID: 27924471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression.
    Hon LS; Zhang Z
    Genome Biol; 2007; 8(8):R166. PubMed ID: 17697356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Application of microRNAs in Biomaterial Scaffold-Based Therapies for Bone Tissue Engineering.
    Arriaga MA; Ding MH; Gutierrez AS; Chew SA
    Biotechnol J; 2019 Oct; 14(10):e1900084. PubMed ID: 31166084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.